Related Experiment Video
Updated: Aug 16, 2025
09:06
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
8.4K
The Aging Heart: A Molecular and Clinical Challenge
Davide Lazzeroni1, Andrea Villatore2,3, Gaia Souryal2
1IRCCS Fondazione Don Carlo Gnocchi, 20132 Milan, Italy.
International Journal of Molecular Sciences
|December 23, 2022
Summary
Cardiovascular diseases (CVDs) are common in older adults, presenting unique clinical features. Understanding cardiac aging at a molecular level may improve patient care and identify new therapeutic targets.
Area of Science:
- Cardiology
- Gerontology
- Molecular Biology
Background:
- Aging significantly increases morbidity, particularly cardiovascular diseases (CVDs).
- Common cardiovascular conditions like heart failure and arrhythmias show distinct manifestations in older populations.
- The aging heart exhibits cellular-level modifications in both healthy individuals and those with CVD.
Purpose of the Study:
- To explore the physiological and pathological molecular mechanisms of cardiac aging.
- To enhance the clinical management of cardiovascular diseases in older patients.
- To identify novel therapeutic targets for age-related cardiac conditions.
Main Methods:
- Review of current literature on cardiac aging.
- Analysis of cellular and molecular changes in the aging heart.
- Comparison of cardiac aging phenotypes in younger versus older populations.
Main Results:
- Cardiac aging involves specific molecular and cellular alterations.
- Clinical presentations of CVDs in the elderly differ from younger individuals.
- Understanding these changes is crucial for effective treatment.
Conclusions:
- Further knowledge of cardiac aging mechanisms can optimize clinical strategies for elderly patients.
- Identifying molecular targets holds promise for future therapies.
- Addressing age-related cardiac changes is essential for improving cardiovascular health in aging populations.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
23
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
23
01:17Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
01:26Heart Failure III: Clinical Manifestations
34
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
34
01:27Heart Failure I: Introduction
40
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
40
01:30Heart Failure V: Medical Management
19
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
01:26Coronary Artery Disease II: Pathophysiology
23
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23